You are viewing the public part of the archive. Login or request access to view more content.

Displaying 1-6 of 6 results
first frame of video
00:14:01

2010_33

XVIII International AIDS Conference in Vienna. Interview with Richard Marlink, Professor at Harvard School of Public Health. He talks about a symposium on the history of HIV/AIDS and future strategies for ending AIDS, that was planned in Boston in 2011.

2010_33

first frame of video
00:16:51

2008_84_05

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

2008_84_05

first frame of video
00:16:39

2008_82_02

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

2008_82_02

first frame of video
00:16:11

2002_13

David Klatzmann is a french immunologist who has been working in an AIDS group in France since 1981. He talks about the discoveries that CD4-antigens function as receptors for the HIV virus and explains the structure of this relationship in detail.

2002_13

first frame of video
00:17:37

2002_10

Luc Montagnier talks about the complex virology of HIV which makes the AIDS vaccine development so difficult. He also talks about the economic and cultural advantages of using traditional medicine as a part of the ARV therapy in developing countries.

2002_10

first frame of video
00:39:38

2002_1

Opening of the Cent Gardes Conference in Annecy in 2002. Speeches by the Director of Fondation Mérieux, Alain Mérieux, and participants from other institutions working on HIV vaccines. The film maker Staffan Hildebrand holds a speech about Face of AIDS.

2002_1